Significant Development(s)
ARGONAUT is the largest US study to map the gut and immune health of cancer patients. This project will unlock biomarkers for the development of therapeutics for the treatment and prevention of cancer.
Persephone is pioneering the use of synthetic biology for the development of microbial products that impact patient and infant health. Persephone is building an end-to-end platform to industrialize the development of engineered cells that restore health to damaged human ecosystems. The company was founded in the summer of 2017 by synthetic and metabolic engineering pioneers, Stephanie Culler PhD, and Steve Van Dien PhD.
